Bio-Rad Laboratories, Inc. (BIO)
The Company manufactures and supplies the life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate chemical and biological materials, and to identify analyze and purify their components.
Recs
Zacks Rank 2-Buy, Recommendation Outperform, Industry Rank 91 / 217, Target 96.50, Avg Target of 3 analysts 95.67
Recs
fair value~~$132.57
Recs
this is a great value stock
Recs
Increased NIH spending should be a benefit for those companies whose product support biotechnology research. They have been beaten down with the market but maintain strong fundamentals as a group.
Recs
Great management with well balanced healthcare portfolio with a position in tools and diagnostics.
Recs
Healthcare need I say more
Recs
Health market preproducts companies such as Bio-Rad laboratories have a lot of growth potentail.
Recs
Another supplier to Pharma, Biotech, but with the addedd advantage of a month long beating on the stock price. Like others (my personal favoriates being CRL, QGEN), I would bet that over the long haul, suppliers of reagents & technology that support the drug discovery industry to do well. BioRad also has the capabilities to get in the the biomarker arena, which would be good if they can execute properly.
Recs
Recs
Recs
Headed North (or South?...) due to the
Recs
Value play as this stock has recently taken a beating dropping 19% in one month. It hasn't been this low since early October, 2006.
The future looks good for this company, and "buying" on the dip is a good play for BIO.
Recs
War on Terror
Recs
Why bet the field when you can play with the dealer
Recs
new products will give a good lift. i like this one. has consistently outperformed in the past, and i don't see that changing anytime soon

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 15 of 15